Nucleome
A Scientist at Nucleome Therapeutics will drive therapeutic target identification within the Functional Genomics team by expanding primary cell CRISPR workflows and developing bespoke genetic assays. The role involves collaborating with drug discovery and computational teams to validate novel therapeutic programs while maintaining rigorous laboratory practices and data reproducibility.
Headquarters
Oxford, England, United Kingdom
Company Size
11-50 employees
Founded
2019
Nucleome is a biotech company focused on unlocking the non‑coding human genome to discover mechanisms and therapeutic targets for inflammatory diseases. Using a platform that combines large‑scale genomics, epigenomics, single‑cell profiling and functional perturbations, they map regulatory elements and link non‑coding variation to disease biology. The company translates those insights into target prioritization and partnerships with drug developers to advance new precision therapies.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Nucleome.
Nucleome didn’t post a salary, so this is our estimate from similar listings.
22% below the average for this role
Principal Scientist, Functional Genomics
Xaira Therapeutics
Scientist II, Genomics Core
Xaira Therapeutics
Associate Director, Tumor Functional Genomics and Perturbation Analytics
BioLife Plasma Services
Senior Research Officer
The Kids Research Institute Australia
Scientist II, Computational Biology & AI
CRISPR Therapeutics
Scientist II, Cell Line Engineering and CRISPR Screening
The Column Group (TCG)